yeah it has me a bit curious. I broke the news a day before VCR told the market about the latest trial patient death but it was removed. Today I have broken on HC the story that the company will extend its trial of its heart device to those awaiting a transplant and the market is afire.
I reckon I've been helping the mugs. The company still hasn't announced the extension of the trial.
Quite annoying I suppose.
